We use analytics cookies to give us insight into how our website is being used. Learn more in our cookie notice I Accept +

+44 (0) 20 3997 7634 | sales@fbkmed.com

Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.

Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.

13/07/13
Back To News +

Latest Articles

Northern Care Alliance cuts inpatient referral times by three quarters using Bleepa

18/10/23

Bleepa Feedback Medical Feedback PLC

Appointment of in-country managing director

12/09/23

Bleepa Feedback Medical Feedback PLC

Annual results: Laying the foundations for growth

12/09/23

Bleepa Feedback Medical Feedback PLC